poisar

Stocks · News reference

Cerence Narrows FY2026 GAAP EPS Guidance from $(0.07)-$0.15 to $(0.02)-$0.06 vs $0.03 Est; Narrows FY2026 Sales Guidance from $305.000M-$320.000M to $310.000M-$314.000M vs $315.340M Est

BenzingaAug 6, 2026, 8:21 PMBenzinga Newsdesk

Cerence (NASDAQ:CRNC) narrows FY2026 GAAP EPS guidance from $(0.07)-$0.15 to $(0.02)-$0.06 vs $0.03 analyst estimate. Narrows FY2026 sales outlook from $305.000 million-$320.000 million to $310.000 million-$314.000

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 6, 2026, 8:21 PM
Checked
Aug 6, 2026, 8:21 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading